Sex differences in outcomes of primary prevention implantable cardioverter-defibrillator therapy: combined registry data from eleven European countries

Autor: Bert Vandenberk, Gábor Széplaki, Michael Scharfe, Sofieke C. Wijers, Leonard Bergau, Christian Eick, Emilia Kowalczyk, Béla Merkely, Frieder Braunschweig, Georg Schmidt, Juhani Juntilla, Barbora Arendacká, Martin Svetlosak, Anton E. Tuinenburg, Panagiota Flevari, Heikki V. Huikuri, Jesper Hastrup Svendsen, Tim Friede, Jochem Stockinger, David Conen, Rik Willems, Christine S. Zürn, Markus Zabel, Andrzej Lubiński, Beat Schaer, Caspar Lund-Andersen, Eu-Cert-Icd Investigators, Christian Sticherling, Michael Dommasch

Publikováno v: EU-CERT-ICD Investigators 2018, ' Sex differences in outcomes of primary prevention implantable cardioverter-defibrillator therapy : combined registry data from eleven European countries ', Europace, vol. 20, no. 6, pp. 963-970 . https://doi.org/10.1093/europace/eux176

AIMS: Therapy with an implantable cardioverter defibrillator (ICD) is established for the prevention of sudden cardiac death (SCD) in high risk patients. We aimed to determine the effectiveness of primary prevention ICD therapy by analysing registry

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f890d6c06bcc2aebe70cbbb811bea417
https://doi.org/10.1093/europace/eux176